Biotherapy: A New Dimension in Cancer Treatment (original) (raw)

References

1. DeVita, V.T. 1983. Progress in cancer management. Cancer 51:2401–2409.
   Article PubMed Google Scholar
2. Oldham, R.K. 1987. Biotherapy: general principles, pp. 1–20 in Principles of Cancer Biotherapy. R. K. Oldham (ed.). Raven Press, New York.
   Google Scholar
3. Fidler, I.J. and Poste, G. 1985. The cellular heterogeneity of malignant neoplasms: Implications for adjuvant chemotherapy. Semin. Oncol. 12:207–221.
   CAS PubMed Google Scholar
4. Busch, W. 1868. Niederrheinische Gesellschaft fur Natur-und Heilkunde in Bonn. Aus der Sitzung der Medizinischen Sektion vom 13. November 1867. Berlin. Klin. Wschr. 5:137–139.
   Google Scholar
5. Coley, W.B. 1891. Contribution to the knowledge of sarcoma. Ann. Surg. 14:199–220.
   Article CAS PubMed PubMed Central Google Scholar
6. Fidler, I.J. 1984. The generation of tumoricidal activity in macrophages for the treatment of established metastases, pp. 421–437 in Cancer Invasion and Metastases: Biological and Therapeutic Aspects. G. L. Nicholson and L. Milas (eds.), Raven Press, New York.
   Google Scholar
7. Goodright, J.E. and Morton, D.C. 1978. Immunotherapy for malignant disease. Ann. Rev. med. 29:231–253.
   Article Google Scholar
8. Oldham, R.K. and Smalley, R.V. 1984. Immunotherapy: the old and the new. J. Biol. Resp. Modif. 2:1–37.
   Google Scholar
9. Diagnostic and therapeutic technology assessment. BCG immunotherapy in bladder cancer: a reassessment. 1988. JAMA 259:2143–2155.
10. Kawagoe, K. and Masuda, H. 1986. Advanced ovarian cancer treated by intraperitoneal immunotherapy with OK432. Jpn. J. Clin. Oncol. 16:137–142.
    Article CAS PubMed Google Scholar
11. Goldstein, D., Laszlo, J. and Rudnick, S. 1987. Interferon in cancer therapy, pp. 247–272 in Principles of Cancer Biotherapy. R. K. Oldham (ed.), Raven Press, New York.
    Google Scholar
12. Hercerd, T. and Schmidt, R.E. 1988. Characteristics and uses of natural killer cells. Immunology Today 9:291–293.
    Article Google Scholar
13. Rosenberg, S.A., Lotze, M.T., Muul, L.M., Leitman, S., Chang, A.E., Ettinghausen, S.E., Matory, Y.L., Skibber, J.M., Shiloni, E., Vetto, J.T., Seipp, C.A., Simpson, C. and Reichert, C.M. 1985. Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl. J. Med. 313:1485–1492.
    Article CAS PubMed Google Scholar
14. Rosenberg, S.A., Speiss, P. and La Frenieve, R. 1986. A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes. Science 233:1318–1321.
    Article CAS PubMed Google Scholar
15. Stevenson, H.C. and Stevenson, G.W. 1987. Adoptive cellular cancer immunotherapy, pp. 385–397 in Principles of Cancer Biotherapy. R. K. Oldham (ed.), Raven Press, New York.
    Google Scholar
16. Sivam, G., Pearson, J.W., Bohn, W., Oldham, R.K., Sadoff, J.C. and Morgan, A.C. 1987. Immunotoxins to a human melanoma associated antigen: comparison of gelonin with Ricin and other A-chain conjugates. Cancer Res. 47:3169–3173.
    CAS PubMed Google Scholar
17. Reading, C.L. and Takane, Y. 1986. Monoclonal antibody applications in bone marrow transplantation. Biochem. Biophys. Acta. 865:141–170.
    CAS PubMed Google Scholar
18. Moore, M.A.S. 1987. Growth and maturation factors in leukemia, pp. 399–446 in Principles of Cancer Biotherapy. R. K. Oldham (ed.), Raven Press, New York.
    Google Scholar
19. Masui, H., Kawamoto, T., Sato, J.D., Wolf, B., Sato, G. and Mendelsohn, J. 1984. Growth inhibition of human tumor cells in athymic nude mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res. 44:1002–1007.
    CAS PubMed Google Scholar
20. Hanna, M.G. and Key, M.E. 1982. Immunotherapy of metastases enhances subsequent chemotherapy. Science 217:367–369.
    Article PubMed Google Scholar

Download references